Proscillaridin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Proscillaridin
Proscillaridin.png
Systematic (IUPAC) name
5-[(3S,8R,9S,10R,13R,14S,17R)- 14-hydroxy- 10,13-dimethyl- 3-((2R,3R,4R,5R,6R)- 3,4,5-trihydroxy- 6-methyltetrahydro- 2H-pyran-2-yloxy)- 2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro- 1H-cyclopenta[a]phenanthren- 17-yl]- 2H-pyran- 2-one
OR
3β-Rhamnosido- 14β-hydroxybufa- 4,20,22-trienolide
Clinical data
AHFS/Drugs.com International Drug Names
Legal status ?
Identifiers
CAS number 466-06-8 N
ATC code C01AB01
PubChem CID 5284613
ChemSpider 4447658 YesY
UNII KC6BL281EN YesY
ChEMBL CHEMBL600325 YesY
Chemical data
Formula C30H42O8 
Mol. mass 530.650
 N (what is this?)  (verify)

Proscillaridin is a cardiac glycoside, a kind of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). It is of the bufanolide type and can be obtained from plants of the genus Scilla, notably Scilla maritima.[1]

References[edit]

  1. ^ Kedra, M.; Kedrowa, S. (1968). "Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima". Polski tygodnik lekarski (Warsaw, Poland : 1960) 23 (19): 714–716. PMID 4876207.  edit